A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo

Sponsor
Pharmacia (Industry)
Overall Status
Completed
CT.gov ID
NCT00002101
Collaborator
(none)
450
44
10.2

Study Details

Study Description

Brief Summary

To compare the efficacy of clarithromycin/ethambutol with placebo or with rifabutin at two different doses in reducing colony-forming units (CFUs) by 2 or more logarithms in patients with Mycobacterium avium Complex bacteremia and maintaining this response until 16 weeks post-randomization. To assess survival and comparative tolerability among the three treatment regimens.

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

Patients are randomized to receive clarithromycin and ethambutol plus either placebo or rifabutin at one of two doses. Treatment continues indefinitely. AS PER AMENDMENT 04/19/94: Doses of rifabutin have been lowered.

Study Design

Study Type:
Interventional
Masking:
Double
Primary Purpose:
Treatment
Official Title:
A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    13 Years to 0 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion Criteria

    Concurrent Medication:
    Allowed:
    • Isoniazid for TB prophylaxis ONLY.
    Patients must have:
    • HIV infection.

    • MAC infection.

    • Life expectancy of at least 16 weeks.

    Exclusion Criteria

    Co-existing Condition:
    Patients with the following symptoms or conditions are excluded:
    • Perceived unreliability or unavailability for frequent monitoring.
    Concurrent Medication:
    Excluded:
    • Antimycobacterial drugs other than the study drugs.

    • Carbamazepine.

    • Terfenadine.

    • Theophylline.

    Patients with the following prior condition are excluded:

    History of hypersensitivity to rifabutin, rifampin, erythromycin, clarithromycin, azithromycin, or ethambutol.

    Prior Medication:
    Excluded within 7 days prior to study entry:
    • Rifabutin.

    • Rifampin.

    • Ethionamide.

    • Cycloserine.

    • Clofazimine.

    • Ethambutol.

    • Amikacin.

    • Ciprofloxacin.

    • Ofloxacin.

    • Sparfloxacin.

    • Azithromycin.

    • Clarithromycin.

    • Pyrazinamide.

    Excluded within 14 days prior to study entry:
    • Carbamazepine.

    • Terfenadine.

    • Theophylline.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 McDowell Clinic Phoenix Arizona United States 85006
    2 Maricopa Med Research Foundation Phoenix Arizona United States 85008
    3 Bay Harbor Hosp Harbor City California United States 90710
    4 Ctr for Special Immunology Irvine California United States 92718
    5 Combat Group Los Angeles California United States 90028
    6 Cedars Sinai Med Ctr Los Angeles California United States 90048
    7 Highland Gen Hosp / San Francisco Gen Hosp Oakland California United States 946021018
    8 HIV Research Group San Diego California United States 92102
    9 UCSD / Ctr for Special Immunology San Diego California United States 92103
    10 Saint Francis Mem Hosp San Francisco California United States 94109
    11 San Francisco Veterans Administration Med Ctr San Francisco California United States 94121
    12 Sunnyvale Med Clinic Sunnyvale California United States 94086
    13 George Washington Univ Med Ctr Washington District of Columbia United States 20037
    14 Veterans Administration Med Ctr Washington District of Columbia United States 20422
    15 Infectious Disease Consultants Altamonte Springs Florida United States 32701
    16 TheraFirst Med Ctrs Inc Fort Lauderdale Florida United States 33308
    17 Dr Frank Tornaka Fort Lauderdale Florida United States 33316
    18 Gary Richmond MD Fort Lauderdale Florida United States 33316
    19 Dr Nelson Zide Hollywood Florida United States 33021
    20 Ctr for Special Immunology Miami Beach Florida United States 33140
    21 Dr Barry Rodwick Safety Harbor Florida United States 34695
    22 Bay Area AIDS Consortium Tampa Florida United States 33609
    23 Infectious Disease Research Consortium of Georgia Atlanta Georgia United States 30345
    24 Dr Daniel Berger Chicago Illinois United States 60657
    25 Univ of Kansas School of Medicine Wichita Kansas United States 67214
    26 Tulane Univ Med School New Orleans Louisiana United States 701122699
    27 Dr Arnold Markowitz Keego Harbor Michigan United States 48320
    28 Univ of Nebraska Med Ctr / HIV Clinic Omaha Nebraska United States 681985130
    29 East Orange Veterans Administration Med Ctr East Orange New Jersey United States 07018
    30 North Jersey Community Research Initiative Newark New Jersey United States 071032842
    31 Long Island Jewish Med Ctr New Hyde Park New York United States 11042
    32 Chelsea Village Med Ctr / Saint Vincent's Hosp New York New York United States 10014
    33 Community Health Network Rochester New York United States 14620
    34 Nalle Clinic Charlotte North Carolina United States 28207
    35 Polyclinic Med Ctr Harrisburg Pennsylvania United States 17110
    36 Buckley Braffman Stern Med Associates Philadelphia Pennsylvania United States 19107
    37 Charleston Veterans Administration Med Ctr Charleston South Carolina United States 294015799
    38 Dr Alfred F Burnside Jr Columbia South Carolina United States 29204
    39 Central Texas Med Foundation Austin Texas United States 78751
    40 Houston Veterans Administration Med Ctr Houston Texas United States 77030
    41 Univ TX San Antonio Health Science Ctr San Antonio Texas United States 78284
    42 Infectious Disease Physicians Inc Annandale Virginia United States 22203
    43 Univ of Wisconsin School of Medicine Madison Wisconsin United States 53792
    44 Milwaukee County Med Complex Milwaukee Wisconsin United States 53226

    Sponsors and Collaborators

    • Pharmacia

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00002101
    Other Study ID Numbers:
    • 048D
    • CS 087250-999
    First Posted:
    Aug 31, 2001
    Last Update Posted:
    Jun 24, 2005
    Last Verified:
    Jun 1, 1999

    Study Results

    No Results Posted as of Jun 24, 2005